Russell Investments Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-47,531
| Closed | -$748K | – | 3647 |
|
|
2024
Q1 | $748K | Sell |
47,531
-2,380
| -5% | -$36.6K | ﹤0.01% | 2080 |
|
|
2023
Q4 | $805K | Buy |
49,911
+7,326
| +17% | +$93.5K | ﹤0.01% | 2052 |
|
|
2023
Q3 | $542K | Sell |
42,585
-274
| -0.6% | -$3.78K | ﹤0.01% | 2203 |
|
|
2023
Q2 | $603K | Buy |
42,859
+355
| +0.8% | +$5.08K | ﹤0.01% | 2156 |
|
|
2023
Q1 | $657K | Sell |
42,504
-52,064
| -55% | -$869K | ﹤0.01% | 2157 |
|
|
2022
Q4 | $1.55M | Buy |
94,568
+3,814
| +4% | +$62K | ﹤0.01% | 1745 |
|
|
2022
Q3 | $1.68M | Buy |
90,754
+14,896
| +20% | +$234K | ﹤0.01% | 1644 |
|
|
2022
Q2 | $996K | Buy |
75,858
+61,351
| +423% | +$677K | ﹤0.01% | 1964 |
|
|
2022
Q1 | $134K | Sell |
14,507
-4,248
| -23% | -$36.1K | ﹤0.01% | 2522 |
|
|
2021
Q4 | $182K | Sell |
18,755
-69,590
| -79% | -$1.31M | ﹤0.01% | 2742 |
|
|
2021
Q3 | $3M | Sell |
88,345
-18,997
| -18% | -$606K | 0.01% | 1577 |
|
|
2021
Q2 | $3.93M | Buy |
107,342
+33,995
| +46% | +$1.32M | 0.01% | 1500 |
|
|
2021
Q1 | $3.29M | Buy |
73,347
+30,925
| +73% | +$1.44M | 0.01% | 1579 |
|
|
2020
Q4 | $2.42M | Buy |
42,422
+2,181
| +5% | +$129K | ﹤0.01% | 1653 |
|
|
2020
Q3 | $2.06M | Buy |
40,241
+37,346
| +1,290% | +$1.83M | ﹤0.01% | 1668 |
|
|
2020
Q2 | $172K | Buy |
+2,895
| New | +$155K | ﹤0.01% | 2750 |
|
|
2019
Q1 | – | Sell |
-27,318
| Closed | -$574K | – | 3036 |
|
|
2018
Q4 | $574K | Sell |
27,318
-3,336
| -11% | -$82K | ﹤0.01% | 2265 |
|
|
2018
Q3 | $1.19M | Sell |
30,654
-13,444
| -30% | -$497K | ﹤0.01% | 2015 |
|
|
2018
Q2 | $1.74M | Hold |
44,098
| – | – | ﹤0.01% | 1836 |
|
|
2018
Q1 | $884K | Buy |
+44,098
| New | +$1.12M | ﹤0.01% | 2255 |
|
Other funds holding DCPH
Russell Investments Group's DCPH Position: Q2 2024 in Review
Russell Investments Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 47,531 shares — an estimated $748K sold.
Russell Investments Group first reported a position in DCPH in Q1 2018 and held it in 20 quarters. The position peaked at $3.93M in Q2 2021. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Russell Investments Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Russell Investments Group sold 47,531 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $748K.
- Russell Investments Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 20 quarters.
- Russell Investments Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.93M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Russell Investments Group's 13F filing for Q2 2024, filed 8 Aug 2024.